Condition
Psoriatic Arthritis
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 134 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownCreating Health Course Study for People With Rheumatological Conditions and Mood DisordersNCT07180537 · 2025-12-01
RECRUITINGRheumatology Diet StudyNCT06339957 · 2024-03-01
RECRUITINGSafety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesNCT04924270 · 2023-12-13
RECRUITINGTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396 · 2022-04-20
RECRUITINGBiobank for Inflammatory Chronic Diseases and OsteoporosisNCT05039216 · 2021-09-13
RECRUITINGRheumatology Patient Registry and BiorepositoryNCT04402086 · 2020-08-04
RECRUITINGDeployment o the Multidisciplinary Prospective Cohort ImminentNCT04334031 · 2020-07-20
RECRUITINGEvolution and Treatments of Chronic Inflammatory Systemic DiseasesNCT04191395 · 2019-12-11
RECRUITINGTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16
RECRUITINGMedical Follow-up of New Cases of Polyarthritis in Children and Young AdultsNCT07000916 · 2013-09-11
RECRUITINGKorean College of Rheumatology Biologics and Targeted Therapy RegistryNCT01965132 · 2012-12-01
RECRUITINGContinued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study CompletersNCT07791199 · 2026-12-31
NOT_YET_RECRUITINGOcular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic PatientsNCT07810569 · 2026-10-01
NOT_YET_RECRUITINGCARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational RegistryNCT07567378 · 2026-05-01
NOT_YET_RECRUITINGSkin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic DiseasesNCT07329556 · 2026-01-15
NOT_YET_RECRUITINGActivating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory ArthritisNCT06555562 · 2025-10-01
COMPLETEDA Study of SPY072 in Rheumatic DiseaseNCT07148414 · 2025-08-21
ACTIVE_NOT_RECRUITINGA Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi ArabiaNCT06714461 · 2025-05-05
COMPLETEDA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)NCT06864026 · 2025-03-06
ACTIVE_NOT_RECRUITINGArtificial Intelligence Literacy and E-Health Literacy in Rheumatic DiseasesNCT07054749 · 2024-12-22
COMPLETEDIxekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightNCT06588296 · 2024-09-24
COMPLETEDINSELMA - a Randomised Controlled TrialNCT06583980 · 2024-09-05
ACTIVE_NOT_RECRUITINGConstruct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic DiseaseNCT06568029 · 2024-08-16
COMPLETEDIntegration of Remote Monitoring in the Management of Chronic Immunosuppressive TherapyNCT06544343 · 2024-07-01
UNKNOWNWORK-ON Vocational Rehabilitation for People With Inflammatory ArthritisNCT06299917 · 2024-03-01
ACTIVE_NOT_RECRUITINGEffect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic DiseasesNCT06277635 · 2024-02-01
UNKNOWNConstruct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint DiseaseNCT07580092 · 2023-11-30
COMPLETEDCohort Project of Patients With Inflammatory RheumatismNCT06059430 · 2023-09-20
NOT_YET_RECRUITINGImpact of Air Pollution on the Course of Inflammatory RheumatismNCT05862584 · 2023-05-26
COMPLETEDRheumatology-based Adaptive Intervention for Social Determinants and Health EquityNCT05715463 · 2023-03-01
ACTIVE_NOT_RECRUITINGSub-cutaneous Infliximab in Inflammatory Rheumatic DiseaseNCT05424926 · 2023-02-24
COMPLETEDThe Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint DiseaseNCT05772325 · 2023-02-20
ACTIVE_NOT_RECRUITINGA Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and PsNCT05866614 · 2023-01-13
ACTIVE_NOT_RECRUITINGThe Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.NCT05913817 · 2023-01-09
COMPLETEDSAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesNCT05598684 · 2022-11-24
UNKNOWNMonitoring of Inflammatory ConditionsNCT05458531 · 2022-06-28
COMPLETEDProspective Analysis of Blood Flow Restriction Training in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Compared to Conventional Strength TrainingNCT07772687 · 2022-06-18
COMPLETEDThe Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory ArthritisNCT05257174 · 2022-06-15
UNKNOWNYuflyma® (Adalimumab), Patient Experience After SwitchingNCT05427942 · 2022-06-03
UNKNOWNImpact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic ArthritisNCT04269993 · 2022-05-18
TERMINATEDAccelerometry in Follow up of Arthritis - a Pilot StudyNCT05301621 · 2022-05-12
UNKNOWNbIosimilar of aDalimumab, an European evAluationNCT05190484 · 2022-04-30
UNKNOWNSurvey About Diet in Chronic Inflammatory Rheumatic DiseasesNCT05283096 · 2022-02-10
UNKNOWNSmall Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid ObesityNCT05225623 · 2022-02-01
COMPLETEDThe Effects of Weight Loss on Psoriatic ArthritisNCT05393141 · 2022-01-30
COMPLETEDCOVID-19 VaccinE Response in Rheumatology PatientsNCT05080218 · 2021-11-15
COMPLETEDVaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19NCT05115370 · 2021-11-01
COMPLETEDDo Nanobubbles Improve Joint Hypoxia?NCT04844008 · 2021-10-05
WITHDRAWNProspective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid OxygenNCT04804449 · 2021-10-04
COMPLETEDImproved Cardiovascular Health for Patients With Inflammatory Joint DiseasesNCT04922840 · 2021-08-09
COMPLETEDTapering of Biologics in Inflammatory Arthritis Patients in RemissionNCT04429776 · 2021-05-13
UNKNOWNVaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationNCT04798625 · 2021-02-15
ACTIVE_NOT_RECRUITINGCOVID-19 Vaccination in Rheumatic Disease PatientsNCT04839315 · 2021-02-15
TERMINATEDClinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' NailsNCT04709354 · 2021-01-01
COMPLETEDArthroscopic Synovectomy of the Wrist in Inflammatory ArthritisNCT04755127 · 2021-01-01
UNKNOWNSeroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic DiseasesNCT04655612 · 2020-12-01
COMPLETEDIMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORTNCT04347798 · 2020-11-01
COMPLETEDThe Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01
COMPLETEDA Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseNCT05051943 · 2020-09-29
COMPLETEDInformation and Acceptability of BiosimilarsNCT04321291 · 2020-07-02
UNKNOWNCommon interventions
PlaceboDRUG5no interventionOTHER4AdalimumabDRUG3EtanerceptDRUG3QuestionnaireOTHER3TirzepatideDRUG3Certolizumab PegolBIOLOGICAL2InfliximabDRUG2IxekizumabDRUG2PlaceboOTHER2UpadacitinibDRUG211th grade reading level arthritis materialsBEHAVIORAL140 mg MSB11022DRUG199mTc-anti-TNF-alpha ScintigraphyOTHER1A.L.P.S. Proximal Humerus Plating SystemDEVICE1AbataceptDRUG1AbbVie Care 2.0BEHAVIORAL1AdalimumabBIOLOGICAL1Akcelerometry follow upOTHER1anti-TNF therapy (etanercept or adalimumab)DRUG1Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)DRUG1Arthroscopic synovectomy of the wristPROCEDURE1AVT02 (Alvotech Biosimilar to Adalimumab)BIOLOGICAL1BaricitinibDRUG1bDMARDSDRUG1
Leading sponsors
Diakonhjemmet Hospital
5
AbbVie
4
AbbVie (prior sponsor, Abbott)
4
Pfizer
4
Karolinska Institutet
3
University of Oxford
3
Abbott
2
Assistance Publique - Hôpitaux de Paris
2
Brigham and Women's Hospital
2
Bristol-Myers Squibb
2
Centre Hospitalier Universitaire de Nice
2
Eli Lilly and Company
2
Fresenius Kabi
2
Momentum Data
2
Salome Kristensen
2
Trial status mix
COMPLETED69
UNKNOWN22
ACTIVE_NOT_RECRUITING13
RECRUITING11
TERMINATED7
NOT_YET_RECRUITING5
WITHDRAWN4
AVAILABLE1
ENROLLING_BY_INVITATION1
SUSPENDED1
Phase mix
NA28
PHASE28
PHASE17
PHASE35
PHASE45
EARLY_PHASE12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.